In pancreatic cancer, the activation of tumor-associated macrophage (TAM) Dectin-1 promotes the M2 polarization of TAMs, inhibiting T cell immunity and thus facilitating tumor progression. Here, CLEC7A is linked to pancreatic neoplasm.